1

Paragon 28

#5330

Rank

$1.1B

Marketcap

US United States

Country

Paragon 28
Leadership team

Mr. Albert DaCosta (Co-Founder, Chairman & CEO)

Mr. Stephen M. Deitsch (CFO & Principal Fin. Officer)

Mr. Matthew Jarboe (Chief Commercial Officer)

Products/ Services
Hardware, Manufacturing, Medical, Medical Device
Number of Employees
100 - 500
Headquarters
Englewood, Colorado, United States
Established
2010
Company Registration
SEC CIK number: 0001531978
Revenue
100M - 500M
Traded as
FNA
Social Media
Overview
Location
Summary
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
History

Paragon 28 was founded in 2009 in Los Angeles, California to address unmet needs in the medical device industry. The company has grown rapidly and now serves customers around the world.

Mission
Our mission is to continuously improve the outcomes and experiences of patients with foot and ankle conditions.
Vision
To strategically build a company around the core principles that drive innovation and quality - relentlessly working to advance the science behind foot and ankle surgery.
Key Team

Mr. Jeff Sears (VP of Operations)

Mr. Erik Mickelson (Chief Accounting Officer & Controller)

Jason Edie (Chief Technology Officer)

Matt Brinckman (Sr. VP of Strategy & Investor Relations)

Ms. Michelle Missal (VP & Chief Compliance Officer)

Mr. Jonathan Friedman (Gen. Counsel & Sec.)

Mr. John Shumaker (Exec. VP of Sales - U.S.)

Recognition and Awards
Paragon 28 has won numerous awards for its groundbreaking work in the medical device industry, including an Innovation Award from the American Medical Association and the National Technology & Engineering Award from the US National Institutes of Health.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Paragon 28
Leadership team

Mr. Albert DaCosta (Co-Founder, Chairman & CEO)

Mr. Stephen M. Deitsch (CFO & Principal Fin. Officer)

Mr. Matthew Jarboe (Chief Commercial Officer)

Products/ Services
Hardware, Manufacturing, Medical, Medical Device
Number of Employees
100 - 500
Headquarters
Englewood, Colorado, United States
Established
2010
Company Registration
SEC CIK number: 0001531978
Revenue
100M - 500M
Traded as
FNA
Social Media